Nafamostat (International)
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0081525-10-2
Chemical Formula
C19-H17-N5-O2
Molecular Weight
347
Therapeutic Category
Protease inhibitor
Chemical Name
Benzoic acid, 4-[(aminoiminometyl)amino]-, 6-(aminoiminometyl)-2-naphtalenyl ester
Foreign Names
- Nafamostatum (Latin)
- Nafamostat (German)
- Nafamostat (French)
- Nafamostat (Spanish)
Generic Names
- Nafamostat Mesilate (OS: JAN)
- Nafamostat Mesylate (OS: USAN)
- FUT 175 (IS)
- Nafamostat Mesilate (PH: JP XVII)
Brand Names
- Buipel
Takeda Teva Pharma, Japan - Coahibitor
AY Pharma, Japan - Famoset
Towa Yakuhin, Japan - Futhan
Torii Yakuhin, Japan - Nafamostat
Kobayashi Pharmaceutical, Japan; Sawai Seiyaku, Japan - Nafamostat Mesilate
Fuji Seiyaku, Japan; Kyoshi Mirai, Japan; Nichi-Iko Pharmaceutical, Japan; Tobishi Pharmaceutical, Japan - Nafatat
Nichi-Iko Pharmaceutical, Japan - Naotamin
Asahi Kasei Pharma, Japan - Opsun
Sanwa Kagaku, Japan - Ronastat
Koa Isei, Japan
Glossary
| Term | Definition |
|---|---|
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.